| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/22/2001 | EP1124809A1 Benzoylpyridazines |
| 08/22/2001 | EP1124801A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 08/22/2001 | EP1124797A1 N-arylsulfonyl amino acid omega amides |
| 08/22/2001 | EP1124794A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 08/22/2001 | EP1124577A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 08/22/2001 | EP1124572A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 08/22/2001 | EP1124570A2 Novel neuropilin/growth factor binding and uses thereof |
| 08/22/2001 | EP1124564A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases |
| 08/22/2001 | EP1124560A1 Use of antifungal agents for treating scleroses |
| 08/22/2001 | EP1124554A1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds |
| 08/22/2001 | EP1124548A2 Compositions for the treatment and prevention of cardiovascular diseases |
| 08/22/2001 | EP1124541A1 Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as a coating agent, a binding agent and/or as a film-forming auxiliary agent in pharmaceutical forms of administration |
| 08/22/2001 | EP0785926B1 Carboxylic acid derivatives, their preparation and their use as medicaments |
| 08/22/2001 | EP0777653B1 Dihygropyridine derivatives as bradykinin antagonists |
| 08/22/2001 | EP0752854B1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
| 08/22/2001 | EP0725794B1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
| 08/22/2001 | CN1309663A Anti-angiogenic proteins and methods of use thereof |
| 08/22/2001 | CN1309660A Phosphinous and phosphonic acid derivs. used as medicaments |
| 08/22/2001 | CN1309655A Cyclic compounds useful in treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
| 08/22/2001 | CN1309654A Biphenyl derivs. |
| 08/22/2001 | CN1309645A Biphenylsulfonyl-substd. imidazole derivs., their preparation process, their use as drug or diagnostic agent |
| 08/22/2001 | CN1309644A Biphenylsulfonyl-substd. imidazole derivs., their preparation process, their use as drug or diagnostic agent and drug contg. them |
| 08/22/2001 | CN1309641A Quinoline derivs. |
| 08/22/2001 | CN1309640A Quinoline derivs. |
| 08/22/2001 | CN1309637A Compositions comprising 2-phenyl-indole compounds and estrogen formutations |
| 08/22/2001 | CN1309634A Hydrazine derivs. |
| 08/22/2001 | CN1309633A Diacylhydrazine derivs. as integrain inhibitors |
| 08/22/2001 | CN1309556A Biodegradable sustained-release alginate gels |
| 08/22/2001 | CN1308955A Natural composition for preventing and treating cardiovascular and cerebrovascular diseases and its application |
| 08/22/2001 | CN1308953A Oral liquid for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 08/22/2001 | CN1308946A Chinese patent medicine for treating coronary heart disease and hypertension |
| 08/21/2001 | US6278027 3-Substituted-2-halocycloheptenone compounds and a method for manufacturing same |
| 08/21/2001 | US6278000 Growth-hormone secretagogues |
| 08/21/2001 | US6277989 Quinazoline derivatives as medicaments |
| 08/21/2001 | US6277987 Sulfonylamino acid and sulfonylamino hydroxamic acid derivatives |
| 08/21/2001 | US6277979 KIAA0551 polynucleotides and polypeptides use |
| 08/21/2001 | US6277978 KVLQT1—a long QT syndrome gene |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/21/2001 | US6277872 Antiischemic agents; brain disorders |
| 08/21/2001 | US6277859 Highly selective kappa-opioid agonists useful as analgesics and diuretics with reduced physiological side effects |
| 08/21/2001 | US6277853 Indole derivatives as 5-HT1B and 5-HT1D agonists |
| 08/21/2001 | US6277852 Piperazinyl 5-HT1 agonists and antagonists |
| 08/21/2001 | US6277851 Bicyclic amino-pyrazinone compounds |
| 08/21/2001 | US6277833 3-hydroxy-3-methyl-glutaryl coenzyme a (hgm--coa) reductase inhibitors which retard cholesterol biosynthesis |
| 08/21/2001 | US6277831 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use |
| 08/21/2001 | US6277819 Use of GLP-1 or analogs in treatment of myocardial infarction |
| 08/21/2001 | US6277574 Genes associated with diseases of the kidney |
| 08/21/2001 | US6277393 Systemic and/or local (topical) application of tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases, traumas and damages of nervous system |
| 08/21/2001 | CA2319308C Pharmaceutical agents |
| 08/21/2001 | CA2207348C Benzimidazole derivatives |
| 08/18/2001 | CA2337786A1 New derivatives of phosphonic 6-sulfamoyl-3-quinolyl acids, the process for the preparation thereof and the pharmaceutical compounds containing them |
| 08/18/2001 | CA2337785A1 New derivatives of phosphonic 6-amino or 6-hydrazinosulfonyl-3-quinolinyl acids, the process for the preparation thereof and the pharmaceutical compounds containing them |
| 08/18/2001 | CA2337301A1 New quinolinyl phosphonic aryl or heteroaryl acid derivatives, their preparation process and the pharmaceutical compositions containing same |
| 08/16/2001 | WO2001059153A2 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
| 08/16/2001 | WO2001059128A2 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 08/16/2001 | WO2001059107A1 Novel scavenger receptors |
| 08/16/2001 | WO2001059106A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/16/2001 | WO2001059103A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | WO2001059084A1 Protein c derivatives |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | WO2001058954A2 Trade molecules and uses related thereto |
| 08/16/2001 | WO2001058935A2 FACTOR VII OR VIIa-LIKE MOLECULES |
| 08/16/2001 | WO2001058921A2 Methods and compositions for generating angiostatin |
| 08/16/2001 | WO2001058906A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058902A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058899A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 08/16/2001 | WO2001058897A1 Benzthiazoles as tnf and pde-iv inhibitors |
| 08/16/2001 | WO2001058896A1 Benzoxazole derivatives as tnf and pde iv inhibitors |
| 08/16/2001 | WO2001058895A1 Benzofuran carboxamides and their therapeutic use |
| 08/16/2001 | WO2001058893A2 Indol-3-yl derivatives and their use as integrin inhibitors |
| 08/16/2001 | WO2001058892A1 Tyrosine derivatives with anti-leukotriene activity |
| 08/16/2001 | WO2001058886A1 Dipeptide nitrile cathepsin k inhibitors |
| 08/16/2001 | WO2001058882A1 Use of pyrimidine endothelin antagonists in companion animals |
| 08/16/2001 | WO2001058879A1 2-phenylcarbamoyl-benzimidazoles |
| 08/16/2001 | WO2001058878A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
| 08/16/2001 | WO2001058875A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 08/16/2001 | WO2001058483A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES |
| 08/16/2001 | WO2001058473A1 Method of treating or inhibiting cellular injury or cell death |
| 08/16/2001 | WO2001058462A2 Models, methods and materials relating to clinical conditions associated with reactive oxygen species |
| 08/16/2001 | WO2001058454A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor |
| 08/16/2001 | WO2001058443A1 TNF- α INHIBITORS |
| 08/16/2001 | WO2001058283A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | WO2001051047A8 Use of fumaric acid derivatives for treating mitochondrial diseases |
| 08/16/2001 | WO2001012180A3 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune responce |
| 08/16/2001 | WO2001009115A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE |
| 08/16/2001 | WO2001009096A3 Potassium channel openers |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001007595A3 Novel fibroblast growth factor and nucleic acids encoding same |
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | WO2000066106A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | WO2000041531A3 Serine protease inhibitors |
| 08/16/2001 | WO1999050658A3 Methods and compounds for modulating nuclear receptor activity |
| 08/16/2001 | US20010014740 Method of producing heterocyclic derivatives |
| 08/16/2001 | US20010014696 Therapeutic compositions (II) |
| 08/16/2001 | US20010014695 Therapy for degradation diseases; oxidation resistance |
| 08/16/2001 | US20010014689 Nervous system disorders |
| 08/16/2001 | US20010014677 Restenosis, kidney diseases, lung diseases |
| 08/16/2001 | US20010014669 Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin |